☰

Erica J. Carrier, Ph.D. - Publications

Affiliations: 
Medical College of Wisconsin, Milwaukee, WI, United States 
Area:
Neuropharmacology
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 West JD, Galindo CL, Kim K, Shin JJ, Atkinson JB, Macias-Perez I, Pavliv L, Knollmann BC, Soslow JH, Markham LW, Carrier EJ. Antagonism of the Thromboxane-Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy. Journal of the American Heart Association. 8: e011902. PMID 31662020 DOI: 10.1161/Jaha.118.011902  0.311
2019 West JD, Kim K, Suzuki T, Moore C, Knollmann BC, Carrier EJ. Abstract 824: Thromboxane/Prostanoid Receptor Activation Increases Calpain-Mediated Proteolysis and Alters Calcium Handling and Fibrosis Following Right Ventricular Pressure Overload Circulation Research. 125. DOI: 10.1161/Res.125.Suppl_1.824  0.34
2018 Carrier EJ, Galindo CL, Kim K, Macias-Perez I, Pavliv L, Shin JJ, Knollmann BC, Soslow JH, Markham LW, West JD. Abstract 397: Preventing Cardiomyopathy of Muscular Dystrophy Through Antagonism of the Thromboxane/Prostanoid Receptor Circulation Research. 123. DOI: 10.1161/Res.123.Suppl_1.397  0.407
2017 Suzuki T, Carrier EJ, Talati MA, Rathinasabapathy A, Chen X, Nishimura R, Tada Y, Tatsumi K, West JD. Isolation and characterization of endothelial-to-mesenchymal transition-cells in pulmonary arterial hypertension. American Journal of Physiology. Lung Cellular and Molecular Physiology. ajplung.00296.2017. PMID 28935639 DOI: 10.1152/Ajplung.00296.2017  0.336
2017 Gaskill CF, Carrier EJ, Kropski JA, Bloodworth NC, Menon S, Foronjy RF, Taketo MM, Hong CC, Austin ED, West JD, Means AL, Loyd JE, Merryman WD, Hemnes AR, De Langhe S, et al. Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction. The Journal of Clinical Investigation. PMID 28463231 DOI: 10.1172/Jci88629  0.327
2016 West JD, Voss BM, Pavliv L, de Caestecker M, Hemnes AR, Carrier EJ. Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload. Pulmonary Circulation. 6: 211-23. PMID 27252848 DOI: 10.1086/686140  0.379
2016 West JD, Carrier EJ, Bloodworth NC, Schroer AK, Chen P, Ryzhova LM, Gladson S, Shay S, Hutcheson JD, Merryman WD. Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension. Plos One. 11: e0148657. PMID 26863209 DOI: 10.1371/Journal.Pone.0148657  0.344
2010 Hill MN, Titterness AK, Morrish AC, Carrier EJ, Lee TT, Gil-Mohapel J, Gorzalka BB, Hillard CJ, Christie BR. Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus. 20: 513-23. PMID 19489006 DOI: 10.1002/Hipo.20647  0.674
2009 Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ. Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress. Psychoneuroendocrinology. 34: 1257-62. PMID 19394765 DOI: 10.1016/J.Psyneuen.2009.03.013  0.621
2008 Hill MN, Carrier EJ, McLaughlin RJ, Morrish AC, Meier SE, Hillard CJ, Gorzalka BB. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. Journal of Neurochemistry. 106: 2322-36. PMID 18643796 DOI: 10.1111/J.1471-4159.2008.05567.X  0.663
2008 Hill MN, Carrier EJ, Ho WS, Shi L, Patel S, Gorzalka BB, Hillard CJ. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus. 18: 221-6. PMID 18058925 DOI: 10.1002/Hipo.20386  0.746
2007 Hill MN, Barr AM, Ho WS, Carrier EJ, Gorzalka BB, Hillard CJ. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. Journal of Neurochemistry. 103: 47-56. PMID 17561935 DOI: 10.1111/J.1471-4159.2007.04688.X  0.673
2007 Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, et al. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nature Medicine. 13: 492-7. PMID 17401376 DOI: 10.1038/Nm1561  0.598
2006 Carrier EJ, Auchampach JA, Hillard CJ. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proceedings of the National Academy of Sciences of the United States of America. 103: 7895-900. PMID 16672367 DOI: 10.1073/Pnas.0511232103  0.607
2005 Carrier EJ, Patel S, Hillard CJ. Endocannabinoids in neuroimmunology and stress. Current Drug Targets. Cns and Neurological Disorders. 4: 657-65. PMID 16375683 DOI: 10.2174/156800705774933023  0.697
2005 Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. Journal of Neurochemistry. 95: 437-45. PMID 16086683 DOI: 10.1111/J.1471-4159.2005.03380.X  0.645
2005 Patel S, Carrier EJ, Ho WS, Rademacher DJ, Cunningham S, Reddy DS, Falck JR, Cravatt BF, Hillard CJ. The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity. Journal of Lipid Research. 46: 342-9. PMID 15576840 DOI: 10.1194/Jlr.M400377-Jlr200  0.625
2005 Hill MN, Patel S, Carrier EJ, Rademacher DJ, Ormerod BK, Hillard CJ, Gorzalka BB. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 508-15. PMID 15525997 DOI: 10.1038/Sj.Npp.1300601  0.693
2004 Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. Molecular Pharmacology. 65: 999-1007. PMID 15044630 DOI: 10.1124/Mol.65.4.999  0.737
2004 Rademacher DJ, Kearn CS, Carrier EJ, Patel S, Delgado MA, Barkmeier A, Klick DE, Breese NM, Pfister SL, Nithipatikom K, Campbell WB, Hillard CJ. Production of hydroxyeicosatetraenoic acids and prostaglandins by a novel rat microglial cell line. Journal of Neuroimmunology. 149: 130-41. PMID 15020073 DOI: 10.1016/J.Jneuroim.2003.12.022  0.686
2003 Benito C, Núñez E, Tolón RM, Carrier EJ, Rábano A, Hillard CJ, Romero J. Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 11136-41. PMID 14657172 DOI: 10.1523/Jneurosci.23-35-11136.2003  0.601
2003 Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ. The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. British Journal of Pharmacology. 139: 1005-13. PMID 12839875 DOI: 10.1038/Sj.Bjp.0705334  0.673
1991 Girardin E, Garoscio-Cholet M, Dechaud H, Lejeune H, Carrier E, Tourniaire J, Pugeat M. Glucocorticoid receptors in lymphocytes in anorexia nervosa Clinical Endocrinology. 35: 79-84. PMID 1889142  0.325
Show low-probability matches.